Abstract
Pigmentary abnormalities of the lower female genital tract most commonly affect the vulva and only rarely the vagina. They are identified in about 10% of patients at routine gynecological examination and encompass melanocytic proliferations as well as non-melanocytic disorders including squamous lesions and inflammatory and reactive conditions. Only the true melanocytic proliferations as well as disorders characterized by hyperpigmentation are discussed in this chapter. The vast majority of pigmented lesions are benign, most frequently presenting as common acquired melanocytic nevi and genital lentigines/melanosis. In contrast, genital melanoma is a rare disease but early detection is crucial due to its poor prognosis at advanced stage. Its correct diagnosis may be challenging due to significant clinical and histological overlap with a subset of benign nevi, in particular the dysplastic and the atypical genital nevi. The salient clinical and histological features of these important entities are discussed in the appropriate context and with a particular focus on differential diagnosis.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mannone F, De Giorgi V, Cattaneo A, Massi D, De Magnis A, Carli P. Dermoscopic features of mucosal melanosis. Dermatol Surg. 2004;30(8):1118–23.
Rock B. Pigmented lesions of the vulva. Dermatol Clin. 1992;10(2):361–70.
Ferrari A, Buccini P, Covello R, et al. The ringlike pattern in vulvar melanosis: a new dermoscopic clue for diagnosis. Arch Dermatol. 2008;144(8):1030–4.
Ronger-Savle S, Julien V, Duru G, Raudrant D, Dalle S, Thomas L. Features of pigmented vulval lesions on dermoscopy. Br J Dermatol. 2011;164(1):54–61.
Jackson R. Melanosis of the vulva. J Dermatol Surg Oncol. 1984;10(2):119–21.
Lenane P, Keane CO, Connell BO, Loughlin SO, Powell FC. Genital melanotic macules: clinical, histologic, immunohistochemical, and ultrastructural features. J Am Acad Dermatol. 2000;42(4):640–4.
Barnhill RL, Albert LS, Shama SK, Goldenhersh MA, Rhodes AR, Sober AJ. Genital lentiginosis: a clinical and histopathologic study. J Am Acad Dermatol. 1990;22(3):453–60.
Sison-Torre EQ, Ackerman AB. Melanosis of the vulva. A clinical simulator of malignant melanoma. Am J Dermatopathol. 1985;7(Suppl):51–60.
Kerley SW, Blute ML, Keeney GL. Multifocal malignant melanoma arising in vesicovaginal melanosis. Arch Pathol Lab Med. 1991;115(9):950–2.
Lee RB, Buttoni Jr L, Dhru K, Tamimi H. Malignant melanoma of the vagina: a case report of progression from preexisting melanosis. Gynecol Oncol. 1984;19(2):238–45.
Kemmett D, Ellis J, Spencer MJ, Hunter JA. The Laugier-Hunziker syndrome – a clinical review of six cases. Clin Exp Dermatol. 1990;15(2):111–4.
Veraldi S, Cavicchini S, Benelli C, Gasparini G. Laugier-Hunziker syndrome: a clinical, histopathologic, and ultrastructural study of four cases and review of the literature. J Am Acad Dermatol. 1991;25(4):632–6.
Lenane P, Sullivan DO, Keane CO, Loughlint SO. The Laugier-Hunziker syndrome. J Eur Acad Dermatol Venereol. 2001;15(6):574–7.
Lampe AK, Hampton PJ, Woodford-Richens K, Tomlinson I, Lawrence CM, Douglas FS. Laugier-Hunziker syndrome: an important differential diagnosis for Peutz-Jeghers syndrome. J Med Genet. 2003;40(6):e77.
Pandolfino TL, Cotell S, Katta R. Pigmented vulvar macules as a presenting feature of the Carney complex. Int J Dermatol. 2001;40(11):728–30.
Rudolph RI. Vulvar melanosis. J Am Acad Dermatol. 1990;23(5 Pt 2):982–4.
Estrada R, Kaufman R. Benign vulvar melanosis. J Reprod Med. 1993;38(1):5–8.
Al-Shraim MM. Angiomatoid giant cellular blue nevus of vaginal wall associated with pregnancy. Diagn Pathol. 2011;6:32.
Tobon H, Murphy AI. Benign blue nevus of the vagina. Cancer. 1977;40(6):3174–6.
Heim K, Hopfl R, Muller-Holzner E, Bergant A, Dapunt O. Multiple blue nevi of the vagina. A case report. J Reprod Med. 2000;45(1):42–4.
Ribe A. Melanocytic lesions of the genital area with attention given to atypical genital nevi. J Cutan Pathol. 2008;35 Suppl 2:24–7.
Polat M, Topcuoglu MA, Tahtaci Y, Hapa A, Yilmaz F. Spitz nevus of the genital mucosa. Indian J Dermatol Venereol Leprol. 2009;75(2):167–9.
Yamazhan M, Ertas IE, Kandiloglu G, Ozeren M. Cellular blue nevus of the vulva mimicking Bartholin’s gland abscess in a 15-year-old girl: a case report. Arch Gynecol Obstet. 2012;285:1009–11.
Blickstein I, Feldberg E, Dgani R, Ben-Hur H, Czernobilsky B. Dysplastic vulvar nevi. Obstet Gynecol. 1991;78(5 Pt 2):968–70.
Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol. 2006;19 Suppl 2:S4–20.
Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997;277(18):1439–44.
Halpern AC, Guerry Dt, Elder DE, Trock B, Synnestvedt M, Humphreys T. Natural history of dysplastic nevi. J Am Acad Dermatol. 1993;29(1):51–7.
Friedman RJ, Ackerman AB. Difficulties in the histologic diagnosis of melanocytic nevi on the vulvae of premenopausal women. In: Ackerman AB, editor. Pathology of malignant melanoma. New York: Masson; 1981. p. 119.
Hosler GA, Moresi JM, Barrett TL. Nevi with site-related atypia: a review of melanocytic nevi with atypical histologic features based on anatomic site. J Cutan Pathol. 2008;35(10):889–98.
Christensen WN, Friedman KJ, Woodruff JD, Hood AF. Histologic characteristics of vulvar nevocellular nevi. J Cutan Pathol. 1987;14(2):87–91.
Brenn T. Atypical genital nevus. Arch Pathol Lab Med. 2011;135(3):317–20.
Gleason BC, Hirsch MS, Nucci MR, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32(1):51–7.
Clark Jr WH, Hood AF, Tucker MA, Jampel RM. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol. 1998;29(1 Suppl 1):S1–24.
Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol. 2002;138(1):77–87.
Nguyen LP, Emley A, Wajapeyee N, Green MR, Mahalingam M. BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi. Br J Dermatol. 2010;162(3):677–80.
Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlof B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer. 1999;86(7):1285–93.
Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol. 1994;171(5):1225–30.
Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol. 2011;122(3):612–7.
Stang A, Streller B, Eisinger B, Jockel KH. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol. 2005;96(1):216–21.
Raber G, Mempel V, Jackisch C, et al. Malignant melanoma of the vulva. Report of 89 patients. Cancer. 1996;78(11):2353–8.
Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol. 2007;110(2 Pt 1):296–301.
Egan CA, Bradley RR, Logsdon VK, Summers BK, Hunter GR, Vanderhooft SL. Vulvar melanoma in childhood. Arch Dermatol. 1997;133(3):345–8.
Hu DN, Yu GP, McCormick SA. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res. 2010;20(2):153–8.
Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B. 2010;101(2):179–83.
Wechter ME, Gruber SB, Haefner HK, et al. Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol. 2004;50(4):554–62.
Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlof B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer. 1999;86(7):1273–84.
Verschraegen CF, Benjapibal M, Supakarapongkul W, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer. 2001;11(5):359–64.
Raspagliesi F, Ditto A, Paladini D, et al. Prognostic indicators in melanoma of the vulva. Ann Surg Oncol. 2000;7(10):738–42.
Bradgate MG, Rollason TP, McConkey CC, Powell J. Malignant melanoma of the vulva: a clinicopathological study of 50 women. Br J Obstet Gynaecol. 1990;97(2):124–33.
Irvin Jr WP, Legallo RL, Stoler MH, Rice LW, Taylor Jr PT, Andersen WA. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol. 2001;83(3):457–65.
Suwandinata FS, Bohle RM, Omwandho CA, Tinneberg HR, Gruessner SE. Management of vulvar melanoma and review of the literature. Eur J Gynaecol Oncol. 2007;28(3):220–4.
Trimble EL, Lewis Jr JL, Williams LL, et al. Management of vulvar melanoma. Gynecol Oncol. 1992;45(3):254–8.
Trifiro G, Travaini LL, Sanvito F, et al. Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma. Eur J Nucl Med Mol Imaging. 2010;37(4):736–41.
Mulvany NJ, Sykes P. Desmoplastic melanoma of the vulva. Pathology. 1997;29(2):241–5.
Creasman WT, Phillips JL, Menck HR. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg. 1999;188(6):670–5.
Frumovitz M, Etchepareborda M, Sun CC, et al. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010;116(6):1358–65.
Gupta D, Malpica A, Deavers MT, Silva EG. Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 2002;26(11):1450–7.
Borazjani G, Prem KA, Okagaki T, Twiggs LB, Adcock LL. Primary malignant melanoma of the vagina: a clinicopathological analysis of 10 cases. Gynecol Oncol. 1990;37(2):264–7.
Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer. 1993;71(5):1893–7.
Cobellis L, Calabrese E, Stefanon B, Raspagliesi F. Malignant melanoma of the vagina. A report of 15 cases. Eur J Gynaecol Oncol. 2000;21(3):295–7.
Edwards RH, Ward MR, Wu H, et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet. 2004;41(4):270–2.
Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47.
Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.
Yun J, Lee J, Jang J, et al. KIT amplification and gene mutations in acral/mucosal melanoma in Korea. APMIS. 2011;119(6):330–5.
Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340–6.
Omholt K, Grafstrom E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res. 2011;17(12):3933–42.
Guo J, Si L, Kong Y, et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol. 2011;29(21):2904–9.
Carvajal RD, Antonescu CR, Wolchok JD, et al. KIT as a therapeutic target in metastatic melanoma. JAMA. 2011;305(22):2327–34.
Jiang X, Zhou J, Yuen NK, et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin Cancer Res. 2008;14(23):7726–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Brenn, T., Calonje, E. (2013). Melanoctyic Lesions of the Vulva and Vagina. In: Brown, L. (eds) Pathology of the Vulva and Vagina. Essentials of Diagnostic Gynecological Pathology. Springer, London. https://doi.org/10.1007/978-0-85729-757-0_5
Download citation
DOI: https://doi.org/10.1007/978-0-85729-757-0_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-756-3
Online ISBN: 978-0-85729-757-0
eBook Packages: MedicineMedicine (R0)